Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VRC 705: Zika Virus DNA Vaccine in Healthy Adults and Adolescents
NCT03110770Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2017
- Primary completion
- Oct 2019
- Countries
- 9
01
Overview
A Phase 2 trial of VRC-ZKADNA090-00-VP in Zika virus infection, sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2017; status: completed.
02
Drugs
VRC-ZKADNA090-00-VP
03
Conditions
Zika virus infection
Beyond the preview
Go deeper on NCT03110770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03110770.